Chris Moyses

1.3k total citations · 1 hit paper
12 papers, 1.0k citations indexed

About

Chris Moyses is a scholar working on Physiology, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chris Moyses has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chris Moyses's work include Diabetes Treatment and Management (4 papers), Smoking Behavior and Cessation (3 papers) and Lysosomal Storage Disorders Research (3 papers). Chris Moyses is often cited by papers focused on Diabetes Treatment and Management (4 papers), Smoking Behavior and Cessation (3 papers) and Lysosomal Storage Disorders Research (3 papers). Chris Moyses collaborates with scholars based in United Kingdom, Australia and Denmark. Chris Moyses's co-authors include Terry D. Butters, Ari Zimran, Johannes M. F. G. Aerts, Frances M. Platt, Deborah Elstein, Raymond A. Dwek, Robin Lachmann, Timothy M. Cox, Sonja van Weely and Martin Hřebı́ček and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Chris Moyses

12 papers receiving 981 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis

2000 592 citations Timothy M. Cox, Robin Lachmann et al. The Lancet profile →

Peers

Chris Moyses

PHYSI

OC

MB

CB

EPIDE

B. J. H. M. Poorthuis Netherlands

Tom Litjens Australia

Jennifer R. Toone Canada

Krisztina Hegyi Hungary

Eiji Takeda Japan

Barbara Rembiesa United States

Serena Catarzi Italy

Karen L. Madsen Denmark

Eric Crombez United States

Ricardo Flores Pires Brazil

B. J. H. M. Poorthuis Netherlands

Chris Moyses

432 ×0.6

PHYSI

83 ×0.2

OC

342 ×1.1

MB

159 ×0.6

CB

191 ×0.7

EPIDE

Citations per year, relative to Chris Moyses Chris Moyses (= 1×) peers B. J. H. M. Poorthuis

Countries citing papers authored by Chris Moyses

Since Specialization

Citations

This map shows the geographic impact of Chris Moyses's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Moyses with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Moyses more than expected).

Fields of papers citing papers by Chris Moyses

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Moyses. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Moyses. The network helps show where Chris Moyses may publish in the future.

Co-authorship network of co-authors of Chris Moyses

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Moyses. A scholar is included among the top collaborators of Chris Moyses based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Moyses. Chris Moyses is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Brazier, J S, et al.. (2015). No Quantifiable Carbonyls, Including Formaldehyde, Detected in Voke^® Inhaler. Journal of Liquid Chromatography & Related Technologies. 38(18). 1687–1690. 3 indexed citations

2.

Moyses, Chris, Alex Hearn, & Andrew Redfern. (2014). Evaluation of a Novel Nicotine Inhaler Device: Part 1—Arterial and Venous Pharmacokinetics. Nicotine & Tobacco Research. 17(1). 18–25. 5 indexed citations

3.

Moyses, Chris, Alex Hearn, & Andrew Redfern. (2014). Evaluation of a Novel Nicotine Inhaler Device: Part 2—Effect on Craving and Smoking Urges. Nicotine & Tobacco Research. 17(1). 26–33. 8 indexed citations

4.

Mok, Tony, Thomas W. T. Leung, Chris Moyses, et al.. (2004). A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer. Acta Oncologica. 43(3). 245–251. 5 indexed citations

5.

Moyses, Chris. (2003). Substrate reduction therapy: clinical evaluation in type 1 Gaucher disease. Philosophical Transactions of the Royal Society B Biological Sciences. 358(1433). 955–960. 36 indexed citations

6.

Platt, Frances M., Mylvaganam Jeyakumar, Ulrika Andersson‐Hall, et al.. (2001). Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy. Journal of Inherited Metabolic Disease. 24(2). 275–290. 92 indexed citations

7.

Cox, Timothy M., Robin Lachmann, C. E. Hollak, et al.. (2000). Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. The Lancet. 355(9214). 1481–1485. 592 indexed citations breakdown →

8.

Nyholm, B., L. Ørskov, Claus Højbjerg Gravholt, et al.. (1999). The amylin analog pramlintide improves glycemic control and reduces postprandial glucagon concentrations in patients with type 1 diabetes mellitus. Metabolism. 48(7). 935–941. 85 indexed citations

9.

Kong, Marie‐France, P. King, Ian Macdonald, et al.. (1997). Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM. Diabetologia. 40(1). 82–88. 102 indexed citations

10.

Nyholm, B., Niels Møller, Claus Højbjerg Gravholt, et al.. (1996). Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus.. The Journal of Clinical Endocrinology & Metabolism. 81(3). 1083–1089. 32 indexed citations

11.

Moyses, Chris, Andrew Young, & Orville Kolterman. (1996). Modulation of gastric emptying as a therapeutic approach to glycaemic control.. PubMed. 13(9 Suppl 5). S34–8. 12 indexed citations

12.

Kolterman, Orville, Alan Gottlieb, Chris Moyses, & Wayne A. Colburn. (1995). Reduction of Postprandial Hyperglycemia in Subjects With IDDM by Intravenous Infusion of AC137, a Human Amylin Analogue. Diabetes Care. 18(8). 1179–1182. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact